Outcomes of switching from proactive to reactive treatment after developing advanced central neovascular age-related macular degeneration.

Elisa Eleanor CornishVuong NguyenMartin PuzoLouise O' TooleChui Ming Gemmy CheungAndrea VincentTremeur GuillaumieSioe Lan OeiHelena Brosa MorrosDaniel BarthelmesMark C Gillies

Published in: Retina (Philadelphia, Pa.) (2023)

Eyes that switch from proactive to reactive treatment after developing MA and inactive SMFi, can have stable visual outcomes. Physicians should be aware of the risk of a significant loss of vision in eyes with active SMFi that switch to reactive treatment.

Keyphrases

age related macular degeneration
primary care
type diabetes
metabolic syndrome
adipose tissue
glycemic control